Cardlytics (CDLX) IPO Opens 7% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil prices, Treasury yields remain elevated
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Cardlytics (Nasdaq: CDLX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of its IPO
February 9, 2018 6:00 AM ESTADVISORY, Feb. 09, 2018 (GLOBE NEWSWIRE) --
What:Â Cardlytics (Nasdaq: CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, will visit the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).
In honor of the occasion, Scott Grimes, CEO & Co-Founder & Lynne Laube, COO & Co-Founder, will ring the Opening Bell.Â
Where:Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:Friday, February 9, 2018 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â
Cardlytics Media... More
Cardlytics Announces Pricing of Initial Public Offering
February 8, 2018 6:41 PM ESTATLANTA, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cardlytics, Inc., a purchase intelligence platform that helps make marketing more relevant and measurable, today announced the pricing of its initial public offering of 5,400,000 shares of common stock at a price to the public of $13.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Cardlytics. In addition, Cardlytics has granted the underwriters a 30-day option to purchase up to an additional 810,000 shares of common stock. Cardlytics common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol CDLX on February 9, 2018. The... More
